FDA Approves PROGESTERONE — Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. received approval in 2007 for the vaginal formulation of Progesterone (NDA 022057), a move that likely expanded the company’s portfolio in the women's healthcare sector while focusing on patient-friendly delivery methods for high-demand therapies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day